Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

Globus Medical Has The Growth, But What About Value?

On first glance, Globus Medical (NYSE:GMED) looks like it could be one of the unicorns of the med-tech space - a legit growth story that the market hasn't already pushed up to a red-hot valuation. Globus has what seems to be a sustainable culture built around product innovation, and that steady stream of innovative products could be just the ticket for success in a price-constrained implant world. That said, valuation isn't quite the slam-dunk that value investors may hope to see.

As We Knew, Globus Did Well At The End Of 2012

Between the earlier release of Q4 revenue numbers and the results we've seen from other major spine companies like Johnson & Johnson (NYSE:JNJ), Medtronic...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details